Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Erythropoietin as an add-on Treatment for Cognitive Side-effects of Electroconvulsive Therapy

NCT03339596 is registered in ClinicalTrials.gov with Martin Balslev Jørgensen as lead sponsor.

NCT NCT03339596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03339596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Erythropoietin as an add-on Treatment for Cognitive Side-effects of Electroconvulsive Therapy
Lead sponsor
Martin Balslev Jørgensen
Phase
Phase 2
Overall status
Completed
Start date
June 26, 2017
Completion date
February 10, 2023
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar depression, cognitive impairment, ect, unipolar depression